| Christian Senesac Kuhr, MD | |
|
1100 9th Ave, C7 Uro Virginia Mason Medical Center, Seattle, WA 98101-2756 | |
| (206) 223-6175 | |
| (206) 515-5886 |
| Full Name | Christian Senesac Kuhr |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 36 Years |
| Location | 1100 9th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962587774 | NPI | - | NPPES |
| 8156259 | Medicaid | WA | |
| 8013 | Other | INTERNAL ID MOTOR VEHICLE ID | |
| 6471KU | Other | WA | BLUE SHIELD # VM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD00030666 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Mason Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Mason Medical Center | 9830002617 | 825 |
News Archive
The Centers for Disease Control and Prevention report has now confirmed that America is in a national obesity crisis. More than one out of three Americans is obese and it's threatening America's well-being, not only as individuals, but as a country.
A doctor at Scripps Green Hospital this week became the first in California to use a new drug-coated balloon to treat peripheral artery disease in a patient since regulatory approval of the IN.PACT Admiral device in January by the Food and Drug Administration.
The cornerstone of genetics is the loss-of-function experiment. In short, this means that to figure out what exactly gene X is doing in a tissue of interest—be it developing brain cells or a pancreatic tumor—you somehow cut out, switch off or otherwise destroy gene X in that tissue and then watch what happens.
Researchers at the University of Connecticut have found a new way to identify protein mutations in cancer cells. The novel method is being used to develop personalized vaccines to treat patients with ovarian cancer.
› Verified 2 days ago
| Entity Name | Virginia Mason Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801851258 PECOS PAC ID: 9830002617 Enrollment ID: O20031107000383 |
News Archive
The Centers for Disease Control and Prevention report has now confirmed that America is in a national obesity crisis. More than one out of three Americans is obese and it's threatening America's well-being, not only as individuals, but as a country.
A doctor at Scripps Green Hospital this week became the first in California to use a new drug-coated balloon to treat peripheral artery disease in a patient since regulatory approval of the IN.PACT Admiral device in January by the Food and Drug Administration.
The cornerstone of genetics is the loss-of-function experiment. In short, this means that to figure out what exactly gene X is doing in a tissue of interest—be it developing brain cells or a pancreatic tumor—you somehow cut out, switch off or otherwise destroy gene X in that tissue and then watch what happens.
Researchers at the University of Connecticut have found a new way to identify protein mutations in cancer cells. The novel method is being used to develop personalized vaccines to treat patients with ovarian cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christian Senesac Kuhr, MD 1100 9th Ave, Ms M4-pa, Seattle, WA 98101-2756 Ph: (206) 583-6025 | Christian Senesac Kuhr, MD 1100 9th Ave, C7 Uro Virginia Mason Medical Center, Seattle, WA 98101-2756 Ph: (206) 223-6175 |
News Archive
The Centers for Disease Control and Prevention report has now confirmed that America is in a national obesity crisis. More than one out of three Americans is obese and it's threatening America's well-being, not only as individuals, but as a country.
A doctor at Scripps Green Hospital this week became the first in California to use a new drug-coated balloon to treat peripheral artery disease in a patient since regulatory approval of the IN.PACT Admiral device in January by the Food and Drug Administration.
The cornerstone of genetics is the loss-of-function experiment. In short, this means that to figure out what exactly gene X is doing in a tissue of interest—be it developing brain cells or a pancreatic tumor—you somehow cut out, switch off or otherwise destroy gene X in that tissue and then watch what happens.
Researchers at the University of Connecticut have found a new way to identify protein mutations in cancer cells. The novel method is being used to develop personalized vaccines to treat patients with ovarian cancer.
› Verified 2 days ago
Dr. Sandra Jane Hadjinian, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St., Seattle, WA 98195 Phone: 206-520-5000 | |
Dr. Steven Han, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 515 Minor Ave, Suite 200, Seattle, WA 98104 Phone: 206-215-2580 Fax: 206-215-2581 | |
John Steele Mullen, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 515 Minor Ave, Suite 200, Seattle, WA 98104 Phone: 206-215-2580 Fax: 206-215-2581 | |
Jeffrey M Mccracken, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 747 Broadway, Seattle, WA 98122 Phone: 206-386-2043 Fax: 206-386-2508 | |
Dr. Carol Collins, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 272 Health Sciences, 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-616-3294 | |
Dr. Daniel Warren Smith, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9709 3rd Ave Ne, Seattle, WA 98115 Phone: 206-860-4944 | |
Tristan Marriner Nicholson, MD, PHD Urology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-520-5000 |